authors Caro-Vega, Yanink McGowan, Catherine C Sierra-Madero, Juan G Belaunzarán-Zamudio, Pablo F Crabtree-Ramírez, Brenda E Shepherd, Bryan E Grinsztejn, Beatriz Wolff, Marcelo Pape, Jean W Padgett, Denis Gotuzzo, Eduardo
Keywords HIV Latin America antiretroviral therapy durability nonnucleoside reverse transcriptase inhibitor protease inhibitor